cbdMD (YCBD) FCF Margin Growth (1y) (2017 - 2025)
cbdMD (YCBD) FCF Margin Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 427.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 325.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -892.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1,003.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 410.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 39.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 333.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,005.00 |
| Sep 30, 2025 | -831.00 |
| Jun 30, 2025 | -2,092.00 |
| Mar 31, 2025 | 1,167.00 |
| Dec 31, 2024 | -403.00 |
| Sep 30, 2024 | 1,103.00 |
| Jun 30, 2024 | 1,121.00 |
| Mar 31, 2024 | 1,016.00 |
| Dec 31, 2023 | 3,052.00 |
| Sep 30, 2023 | 1,459.00 |
| Jun 30, 2023 | 2,302.00 |
| Mar 31, 2023 | 2,937.00 |
| Dec 31, 2022 | 2,190.00 |
| Sep 30, 2022 | 1,954.00 |
| Jun 30, 2022 | 1,272.00 |
| Mar 31, 2022 | -3,069.00 |
| Dec 31, 2021 | -4,042.00 |
| Sep 30, 2021 | -4,312.00 |
| Jun 30, 2021 | -3,037.00 |
| Mar 31, 2021 | 3,385.00 |